Human immunodeficiency virus treatment failure is possible even in those with low viral load, researchers in Canada say. Claudie Laprise of the University of Montreal, who worked in close collaboration with doctors from the Clinique ...
Tags: Prognosis for HIV, HIV Treatment Good, Anti-Retroviral Therapy
Health Canada has approved Roche's fully automated test, designed to assess a patient's viral load of cytomegalovirus (CMV). The COBAS AmpliPrep / COBAS TaqMan CMV assay is the first approved test, which is standardized to the WHO ...
Tags: Health Canada, CMV, clinical trial
The US Food and Drug Administration (FDA) has approved Roche's new COBAS TaqMan HIV-1 viral load test. The HIV viral load test utilizes the FDA-approved high pure system viral nucleic acid kit for manual specimen preparation and the COBAS ...
Tags: HIV-1 viral load test, COBAS TaqMan, FDA
Roche has gained FDA approval for the new HIV viral load test, the COBAS TaqMan HIV-1 Test, v2.0, and will launch the product in the US, later in 2012. The COBAS TaqMan HIV-1 Test, v2.0, targets two highly conserved regions of the HIV-1 ...
Roche has launched a new FDA-approved dual-target HIV-1 viral load test to improve the ability of physicians to monitor viral load and manage the treatment of people living with human immunodeficiency virus (HIV). The COBAS TaqMan HIV-1 ...
Tags: Viral Load Test, Dual-target HIV-1 Viral Load Test, Roche
The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Roche's new fully automated COBAS AmpliPrep / COBAS TaqMan CMV test to quantify cytomegalovirus' (CMV) DNA in human plasma specimens. The real-time ...
Tags: Roche, FDA, Viral Load Test, PCR-based CMV test